BRIM BIOTECHNOLOGY, INC.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 2013-01-01
- Employees
- 24
- Market Cap
- -
- Website
- http://www.brimbiotech.com
Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
Phase 2
Recruiting
- Conditions
- Neurotrophic Keratitis
- Interventions
- Drug: BRM424 Ophthalmic Solution - Dose1Drug: BRM424 Ophthalmic Solution - Dose2
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- BRIM Biotechnology Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT05927428
- Locations
- 🇺🇸
Wilmington Eye, Leland, North Carolina, United States
Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
Phase 3
Completed
- Conditions
- Dry Eye Disease
- Interventions
- Drug: BRM421 Ophthalmic SolutionDrug: Vehicle
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2024-07-11
- Lead Sponsor
- BRIM Biotechnology Inc.
- Target Recruit Count
- 740
- Registration Number
- NCT05695781
- Locations
- 🇺🇸
Andover Eye Associates, Warwick, Rhode Island, United States
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
- First Posted Date
- 2020-04-13
- Last Posted Date
- 2021-10-21
- Lead Sponsor
- BRIM Biotechnology Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT04343287
- Locations
- 🇺🇸
Eye Research Foundation, Newport Beach, California, United States
🇺🇸Midwest Cornea Associates, LLC, Indianapolis, Indiana, United States
🇺🇸Andover Eye Associates, Andover, Massachusetts, United States
Safety and Efficacy of BRM421 for Dry Eye Syndrome
- First Posted Date
- 2017-02-28
- Last Posted Date
- 2017-11-22
- Lead Sponsor
- BRIM Biotechnology Inc.
- Target Recruit Count
- 157
- Registration Number
- NCT03066219
- Locations
- 🇺🇸
Andover Eye Associates, Andover, Massachusetts, United States
🇺🇸Central Maine Eye Care, Lewiston, Maine, United States
© Copyright 2025. All Rights Reserved by MedPath